191 related articles for article (PubMed ID: 24100313)
1. Structural basis for the antibody neutralization of herpes simplex virus.
Lee CC; Lin LL; Chan WE; Ko TP; Lai JS; Wang AH
Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):1935-45. PubMed ID: 24100313
[TBL] [Abstract][Full Text] [Related]
2. B Virus (Macacine Herpesvirus 1) Divergence: Variations in Glycoprotein D from Clinical and Laboratory Isolates Diversify Virus Entry Strategies.
Patrusheva I; Perelygina L; Torshin I; LeCher J; Hilliard J
J Virol; 2016 Oct; 90(20):9420-32. PubMed ID: 27512063
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
[TBL] [Abstract][Full Text] [Related]
4. Induction of conformational changes at the N-terminus of herpes simplex virus glycoprotein D upon binding to HVEM and nectin-1.
Lazear E; Whitbeck JC; Zuo Y; Carfí A; Cohen GH; Eisenberg RJ; Krummenacher C
Virology; 2014 Jan; 448():185-95. PubMed ID: 24314649
[TBL] [Abstract][Full Text] [Related]
5. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
[TBL] [Abstract][Full Text] [Related]
6. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
Krawczyk A; Krauss J; Eis-Hübinger AM; Däumer MP; Schwarzenbacher R; Dittmer U; Schneweis KE; Jäger D; Roggendorf M; Arndt MA
J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.
Yoon M; Zago A; Shukla D; Spear PG
J Virol; 2003 Sep; 77(17):9221-31. PubMed ID: 12915538
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antiviral potential among soluble forms of herpes simplex virus type-2 glycoprotein D receptors, herpes virus entry mediator A, nectin-1 and nectin-2, in transgenic mice.
Fujimoto Y; Tomioka Y; Ozaki K; Takeda K; Suyama H; Yamamoto S; Takakuwa H; Morimatsu M; Uede T; Ono E
J Gen Virol; 2017 Jul; 98(7):1815-1822. PubMed ID: 28671524
[TBL] [Abstract][Full Text] [Related]
9. Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism.
Manoj S; Jogger CR; Myscofski D; Yoon M; Spear PG
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12414-21. PubMed ID: 15273289
[TBL] [Abstract][Full Text] [Related]
10. Structure of herpes simplex virus glycoprotein D bound to the human receptor nectin-1.
Di Giovine P; Settembre EC; Bhargava AK; Luftig MA; Lou H; Cohen GH; Eisenberg RJ; Krummenacher C; Carfi A
PLoS Pathog; 2011 Sep; 7(9):e1002277. PubMed ID: 21980294
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of herpes simplex virus 2 gD bound to nectin-1 reveals a conserved mode of receptor recognition.
Lu G; Zhang N; Qi J; Li Y; Chen Z; Zheng C; Gao GF; Yan J
J Virol; 2014 Dec; 88(23):13678-88. PubMed ID: 25231300
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry.
Krummenacher C; Nicola AV; Whitbeck JC; Lou H; Hou W; Lambris JD; Geraghty RJ; Spear PG; Cohen GH; Eisenberg RJ
J Virol; 1998 Sep; 72(9):7064-74. PubMed ID: 9696799
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.
Connolly SA; Whitbeck JJ; Rux AH; Krummenacher C; van Drunen Littel-van den Hurk S; Cohen GH; Eisenberg RJ
Virology; 2001 Feb; 280(1):7-18. PubMed ID: 11162814
[TBL] [Abstract][Full Text] [Related]
14. The major neutralizing antigenic site on herpes simplex virus glycoprotein D overlaps a receptor-binding domain.
Whitbeck JC; Muggeridge MI; Rux AH; Hou W; Krummenacher C; Lou H; van Geelen A; Eisenberg RJ; Cohen GH
J Virol; 1999 Dec; 73(12):9879-90. PubMed ID: 10559300
[TBL] [Abstract][Full Text] [Related]
15. Amino acid substitutions in the V domain of nectin-1 (HveC) that impair entry activity for herpes simplex virus types 1 and 2 but not for Pseudorabies virus or bovine herpesvirus 1.
Martinez WM; Spear PG
J Virol; 2002 Jul; 76(14):7255-62. PubMed ID: 12072525
[TBL] [Abstract][Full Text] [Related]
16. Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition.
Uchida H; Shah WA; Ozuer A; Frampton AR; Goins WF; Grandi P; Cohen JB; Glorioso JC
J Virol; 2009 Apr; 83(7):2951-61. PubMed ID: 19129446
[TBL] [Abstract][Full Text] [Related]
17. Using Antibodies and Mutants To Localize the Presumptive gH/gL Binding Site on Herpes Simplex Virus gD.
Atanasiu D; Saw WT; Lazear E; Whitbeck JC; Cairns TM; Lou H; Eisenberg RJ; Cohen GH
J Virol; 2018 Dec; 92(24):. PubMed ID: 30282715
[TBL] [Abstract][Full Text] [Related]
18. Localization of the Interaction Site of Herpes Simplex Virus Glycoprotein D (gD) on the Membrane Fusion Regulator, gH/gL.
Cairns TM; Atanasiu D; Saw WT; Lou H; Whitbeck JC; Ditto NT; Bruun B; Browne H; Bennett L; Wu C; Krummenacher C; Brooks BD; Eisenberg RJ; Cohen GH
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759318
[TBL] [Abstract][Full Text] [Related]
19. Soluble V domain of Nectin-1/HveC enables entry of herpes simplex virus type 1 (HSV-1) into HSV-resistant cells by binding to viral glycoprotein D.
Kwon H; Bai Q; Baek HJ; Felmet K; Burton EA; Goins WF; Cohen JB; Glorioso JC
J Virol; 2006 Jan; 80(1):138-48. PubMed ID: 16352538
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
